In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering ...

The US indices continue to see a lot of choppy behavior, and of course as we are going through earnings season, it makes sense that it would be the case. However, as we continue to move on the latest ...

LifeMD shares surged 22% after announcing plans to offer access to semaglutide, which is marketed as Wegovy to treat obesity, through NovoCare Pharmacy. Shares were trading around $7.49. The stock is ...

S&P Global's first-quarter profit beat analysts' expectations, as demand for its data and analytics offerings remained robust ...

Prices rose 4.5% in February from the year prior, according to the S&P CoreLogic Case-Shiller index tracking 20 large ...

US futures are currently trading below the flat line after some last hour buying aided a recovery in regular trading on ...